Clinical trials
Diabetes (Insulin-requiring, Type 1 or Type 2) clinical trials
Below are recruiting diabetes (insulin-requiring, type 1 or type 2) clinical trials, each written for real people, not researchers. We’re tracking 2,191 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06550687Recruiting
Studying how cancer patients like to learn about genetic results
This trial looks at the best ways to give cancer patients their genetic information before a special test called exome analysis. It aims to make sure you get the information in a way that feels right for you.
DijonAges 18 years+ - NCT04396223RecruitingPhase 1/Phase 2
Avelumab plus methotrexate for low-risk gestational tumor
This study tests whether avelumab (an immune therapy) combined with methotrexate (chemotherapy) can work well as the first treatment for low-risk gestational trophoblastic neoplasia. It aims to improve control of the tumor while keeping side effects acceptable.
Pierre-Bénite, Pierre BéniteAges 18 years+ - NCT07306949RecruitingPhase 4
Acoramidis for transthyretin cardiac amyloidosis
This trial tests a new medicine called acoramidis for people with a heart condition caused by a protein called transthyretin. It includes people who are newly diagnosed or who are already taking another drug (tafamidis) and may benefit from switching. The goal is to see how well acoramidis works and how it affects heart-related measures.
Bunkyō CityAges 18–100 - NCT07622797RecruitingPhase 2
Immunotherapy with chemotherapy and radiation for esophageal cancer
This trial tests a new immunotherapy drug (camrelizumab) combined with standard chemotherapy and radiation to treat advanced esophageal cancer while avoiding surgery if possible. The goal is to shrink the tumor and help you keep your esophagus working.
Luoyang, HenanAges 18 years+ - NCT06874335RecruitingPhase 1
A study of BHV-1530 for advanced solid tumors
This trial tests a new drug, BHV-1530, either alone or with another drug called cemiplimab, for people with certain advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it's safe and effective.
Newport Beach, CaliforniaAges 18 years+ - NCT06579768Recruiting
Using CT scans to predict jaw cyst type before surgery
This study tests if analyzing CT scans with artificial intelligence can help doctors tell the difference between types of jaw cysts before surgery. This could help avoid surgery or choose the best treatment for you.
Guangzhou, GuangdongAges Any age - NCT07019454Recruiting
Custom stent graft for aneurysms near the kidneys
This study tests a doctor-modified stent graft to treat a type of abdominal aortic aneurysm (just above the kidneys). It may be an option if your aneurysm is large, growing, or causing symptoms, and standard devices aren't suitable.
Springfield, MassachusettsAges 18 years+ - NCT07690358Recruiting
Nitrous oxide levels in body after different exposures
This study measures how much nitrous oxide (laughing gas) stays in your blood, breath, and urine after different types of exposure. It helps researchers understand how long the gas remains in the body for safety reasons.
AarhusAges 18–65 - NCT05841472RecruitingPhase 2
Camrelizumab plus chemo for advanced lung cancer without EGFR or ALK
This Phase 2 trial tests whether the immunotherapy drug camrelizumab, combined with pemetrexed and carboplatin, can work better as first treatment for advanced lung cancer that has no EGFR or ALK gene changes. You may be able to join if you have measurable disease, good enough organ function, and meet other safety rules for immune treatment.
AnamAges 19–80 - NCT06675617Recruiting
Stent treatment for type B aortic dissection
This trial tests if a special stent called the Allay® Aortic Stent can help people with a type B aortic dissection that extends to or past the celiac trunk. It may be an option if you've recently had symptoms and are already scheduled for a standard stent procedure.
GenkAges 18 years+ - NCT06672536RecruitingPhase 1/Phase 2
Study of SCT520FF for wet age-related macular degeneration
This trial tests an investigational drug called SCT520FF for people with wet age-related macular degeneration (nAMD). It aims to find the safest dose and check if it can improve vision. You may be eligible if you have active new blood vessels in your eye from nAMD and have not had certain other eye problems.
TianjingAges 45–80 - NCT06830629RecruitingPhase 2
MZE829 for APOL1 kidney disease
This trial tests an experimental drug called MZE829 for people with kidney disease linked to the APOL1 gene. It aims to see if the drug can help protect kidney function.
Decatur, AlabamaAges 18–68 - NCT06650956Recruiting
HPV vaccine and health education for teens in Laos
This trial offers HPV vaccination and sexual health education to 10-13 year old students and out-of-school youth in Laos. It aims to improve health knowledge and vaccination rates.
Muang Sing, ProvinceAges 10–13 - NCT07439458Recruiting
Exercise effects on tumor cells in breast cancer survivors
This trial tests whether different types and intensities of exercise can change tumor-related cells in survivors of triple-negative breast cancer. It may help understand how exercise could improve long-term outcomes.
Riga, Dzirciema Street 16Ages 35 years+ - NCT05872204RecruitingPhase 2
Abemaciclib plus letrozole for rare ER-positive ovarian cancer
This trial tests whether abemaciclib with letrozole can slow or shrink certain rare ovarian cancers that have estrogen receptors. It may help people whose cancer has come back and can be measured on scans, with extra required tissue and blood tests.
Liège, LiègeAges 18 years+ - NCT07095868RecruitingPhase 1/Phase 2
Study of EVM14 for advanced solid tumors
This trial tests a new drug called EVM14, alone or with other treatments, for people with advanced solid tumors that can't be removed by surgery or have spread. It aims to see if the drug is safe and helps shrink or control the cancer.
New York, New YorkAges 18 years+ - NCT05632861RecruitingPhase 2
Trial drug for biopsy-proven nonalcoholic steatohepatitis
This Phase 2 trial studies HuHuangLianzonggan Capsule to treat nonalcoholic steatohepatitis (NASH), a liver inflammation caused by fat buildup. You may be eligible if you have confirmed NASH on a recent liver biopsy and meet specific liver fat, lab, and health-condition limits.
Hefei, AnhuiAges 18–75 - NCT06131775Recruiting
Study of immune cells in blood of people with solid tumors
This study is looking at a specific type of immune cell (called TLR4+ cells) in the blood of people with solid tumors. By studying these cells, researchers hope to learn more about how the immune system reacts to cancer and to treatments.
BronAges 18 years+ - NCT06693752RecruitingPhase 2
Ultrasound test for fluid on the brain in babies
This trial uses a special ultrasound with contrast to study fluid on the brain (hydrocephalus) in newborn babies. The aim is to learn more about the condition and improve treatment options.
Philadelphia, PennsylvaniaAges 1 minute–1.5 years - NCT07012954RecruitingPhase 1/Phase 2
ctDNA-guided treatment for RAS/BRAF wild-type colorectal cancer
This trial tests a combination of two drugs—cetuximab or bevacizumab plus a chemotherapy pill (trifluridine/tipiracil)—for people with metastatic colorectal cancer that has no RAS or BRAF mutations. It's for patients whose cancer grew after first responding to cetuximab, and who have had other treatments since then.
Guangzhou, GuangdongAges 18–75 - NCT05422066RecruitingPhase 2
Selinexor with standard chemo for high-risk lymphoma
This Phase 2 trial studies selinexor added to standard R-CHOP chemotherapy in people with a high-risk type of diffuse large B-cell lymphoma (DLBCL) that is “germinal center B-cell” (GC). It aims to improve disease control in people who need stronger treatment at the start.
Guangzhou, GuangdongAges 18–75 - NCT07317349Recruiting
A study on how a daily time shift affects body rhythms in couples
This study looks at how a small, consistent delay in your daily schedule affects your body's internal clock. It involves you and your partner staying together in a lab for five days.
AarhusAges 23–45 - NCT07327788RecruitingPhase 2
Study of QL1706, bevacizumab, and chemo infusion for liver cancer with portal vein clot
This trial tests a combination of three treatments for people with advanced liver cancer that has spread into the main portal vein. The goal is to see if this therapy can shrink tumors and improve outcomes.
Guangzhou, GuangdongAges 18 years+ - NCT07039591RecruitingEarly Phase 1
Testing a vaginal ring for comfort and use in healthy women
This study tests a non-medicated vaginal ring to see if women find it comfortable and easy to use. If you are a healthy, sexually active woman using non-vaginal birth control, you may be eligible.
Atlanta, GeorgiaAges 18–49
Hear when a new Diabetes (Insulin-requiring, Type 1 or Type 2) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetes (insulin-requiring, type 1 or type 2)?
- Yes. Clin2 currently lists 2,191 recruiting diabetes (insulin-requiring, type 1 or type 2) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetes (insulin-requiring, type 1 or type 2) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetes (insulin-requiring, type 1 or type 2) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.